HOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and full year ended December 31, ...
(1) Other operating expenses for the three months ended December 31, 2024 includes $0.2 million of restructuring-related charges. Other operating expenses for the twelve months ended December 31 ...
electroCore reported record 2024 net sales of $25.2 million, a 57% increase, driven by Rx gammaCore and Truvaga sales growth. electroCore, Inc. reported a record net sales of $25.2 million for the ...
As of 5:52:02 p.m. GMT+1. Market Open. Loading Chart for E3B0.SG ...
"The future favors the brave." ...
"The future favors the brave." ...
Period This Fund Nifty 50 NASDAQ-100 Index Category Average ...
This website is the official website of the Council of the EU and the European Council. It is managed by the General Secretariat of the Council, the body of staff responsible for assisting the Council ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback